Eli Lilly gets US antitrust nod for Novartis animal health business (update*)
American pharmaceutical company Eli Lilly has received antitrust approval to acquire Swiss drugmaker Novartis' animal health business for $5.4 billion, according to a list released by the Federal Trade Commission on Monday. The deal received clearance through...To view the full article, register now.
Already a subscriber? Click here to view full article